| Title of Invention | A CONTROLLED RELEASE DOSAGE FORM FOR ORAL ADMINISTRATION |
|---|---|
| Abstract | The present invention relates to a novel solid matrixed controlled release, oral dosage form where the dosage form contains a therapeutically effective amount of sulfonylurea or salt or derivative thereof in the matrix. Further, the use of an aqueous alkalizing medium affords substantially complete bioavailability of the drug from the matrix of the tablet. The core tablets may optionally be coated with a coating material in the range of 2% to 10% with an enteric material or with a water insoluble material like ethyl cellulose. |
| Full Text |
|---|
833-mas-2000 claims granted.pdf
833-mas-2000 correspondence others.pdf
833-mas-2000 correspondence po.pdf
833-mas-2000 description (complete) granted.pdf
833-mas-2000 power of attorney.pdf
| Patent Number | 216605 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indian Patent Application Number | 833/MAS/2000 | ||||||||||||
| PG Journal Number | 17/2008 | ||||||||||||
| Publication Date | 25-Apr-2008 | ||||||||||||
| Grant Date | 17-Mar-2008 | ||||||||||||
| Date of Filing | 03-Oct-2000 | ||||||||||||
| Name of Patentee | PENWEST PHARMACEUTICALS CO | ||||||||||||
| Applicant Address | 2981 ROUTE 22, PATTERSON, NY 12563-9970, | ||||||||||||
Inventors:
|
|||||||||||||
| PCT International Classification Number | A61K 31/426 | ||||||||||||
| PCT International Application Number | N/A | ||||||||||||
| PCT International Filing date | |||||||||||||
PCT Conventions:
|
|||||||||||||